Shopping Cart
- Remove All
Your shopping cart is currently empty
Tivozanib hydrochloride hydrate (AV-951 hydrochloride hydrate) is an orally active, selective, and potent vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitor that inhibits VEGFR-1, VEGFR-2, and VEGFR-3.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 5 mg | $53 | In Stock | |
| 10 mg | $74 | In Stock | |
| 25 mg | $118 | In Stock | |
| 50 mg | $173 | In Stock | |
| 100 mg | $256 | In Stock | |
| 500 mg | $638 | 7-10 days |
| Description | Tivozanib hydrochloride hydrate (AV-951 hydrochloride hydrate) is an orally active, selective, and potent vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitor that inhibits VEGFR-1, VEGFR-2, and VEGFR-3. |
| Targets&IC50 | VEGFR3:15 nM, VEGFR1:30 nM, VEGFR2:6.5 nM |
| In vitro | Tivozanib hydrochloride hydrate (0-100 nM; 24 hours) inhibited the proliferation of HUVEC cells[1]. |
| In vivo | In the Calu-6 tumor-bearing athymic mice model, Tivozanib hydrochloride hydrate (0.04-1 mg/kg/day; orally, for 14-21 days) inhibits tumor growth, angiogenesis, and vascular permeability[1]. |
| Synonyms | KRN951 hydrochloride hydrate, AV-951 hydrochloride hydrate |
| Molecular Weight | 509.34 |
| Formula | C22H22Cl2N4O6 |
| Cas No. | 682745-41-1 |
| Smiles | O.Cl.COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC |
| Storage | keep away from direct sunlight,keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 100 mg/mL (196.33 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.